| Stage | NDSN | % of rev | TAYD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $818M | 100.00% | $7M | 100.00% | NDSN ×112.01 |
| Gross profit | $454M | 55.49% | $2M | 29.57% | NDSN +25.9pp |
| Operating income | $223M | 27.28% | $38,454 | 0.53% | NDSN +26.8pp |
| Pre-tax income | $186M | 22.74% | $456,933 | 6.26% | NDSN +16.5pp |
| Net income | $153M | 18.69% | $456,933 | 6.26% | NDSN +12.4pp |
| Stage | NDSN | TAYD | Gap · A − B |
|---|---|---|---|
| Revenue | $818M100.00% | $7M100.00% | NDSN ×112.01 |
| Gross profit | 55.49%$454M | 29.57%$2M | NDSN +25.9pp |
| Operating income | 27.28%$223M | 0.53%$38,454 | NDSN +26.8pp |
| Pre-tax income | 22.74%$186M | 6.26%$456,933 | NDSN +16.5pp |
| Net income |
| 18.69%$153M |
| 6.26%$456,933 |
| NDSN +12.4pp |
No disclosed counterparties: NDSN, TAYD.